MedPath

Far Infrared Radiation Treatment for Bipolar Condition

Phase 1
Conditions
Bipolar Disorder
Interventions
Radiation: Far infrared
Registration Number
NCT00573196
Lead Sponsor
GAAD Medical Research Institute Inc.
Brief Summary

A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition

Detailed Description

A 2000 study in the American Journal of Psychiatry reported that, "in those with bipolar, two major areas of the brain contain 30 percent more cells that send signals to other brain cells". This fact explains why famous people with the Bipolar condition like astronaut Buzz Aldrin, financier Robert Campeau, British Prime Minister Winston Churchill, composer Mozart, scientist Isaac Newton, physician Sigmund Freud and media giant \& entrepreneur Ted Turner, excelled in life due to the additional brain power!

The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia
Exclusion Criteria
  • Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Far infrared-
Primary Outcome Measures
NameTimeMethod
The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.2 years
Secondary Outcome Measures
NameTimeMethod
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.2 years

Trial Locations

Locations (1)

The Centre for Incurable Diseases

🇨🇦

Mississauga, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath